iSpecimen Inc. Files 8-K with Corporate Updates
Ticker: ISPC · Form: 8-K · Filed: Sep 11, 2024 · CIK: 1558569
| Field | Detail |
|---|---|
| Company | Ispecimen INC. (ISPC) |
| Form Type | 8-K |
| Filed Date | Sep 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, financials
TL;DR
iSpecimen filed an 8-K on Sept 11, 2024, with major corporate changes and financial updates. Watch closely.
AI Summary
On September 11, 2024, iSpecimen Inc. filed an 8-K report detailing material modifications to the rights of its security holders and amendments to its articles of incorporation or bylaws. The filing also included Regulation FD disclosures and financial statements/exhibits, indicating significant corporate actions and updates for investors.
Why It Matters
This filing signals significant corporate governance changes and provides updated financial information, which could impact investor decisions and the company's strategic direction.
Risk Assessment
Risk Level: medium — Filings detailing modifications to security holder rights and amendments to corporate bylaws can introduce new risks or alter existing ones for investors.
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- September 11, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40501 (filing_id) — Commission File Number
- 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal executive offices
FAQ
What specific modifications were made to the rights of iSpecimen Inc.'s security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item information, but the specific details of these modifications are not provided in the excerpt.
What amendments were made to iSpecimen Inc.'s articles of incorporation or bylaws?
The filing lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item information, but the specific amendments are not detailed in the provided text.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, suggesting that iSpecimen Inc. is making a public announcement of important information.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 11, 2024.
Where are iSpecimen Inc.'s principal executive offices located?
iSpecimen Inc.'s principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.
Filing Stats: 1,038 words · 4 min read · ~3 pages · Grade level 10.9 · Accepted 2024-09-11 16:45:33
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Ma
Filing Documents
- tm2423782d1_8k.htm (8-K) — 34KB
- tm2423782d1_ex3-1.htm (EX-3.1) — 8KB
- tm2423782d1_ex99-1.htm (EX-99.1) — 10KB
- 0001104659-24-098955.txt ( ) — 231KB
- ispc-20240911.xsd (EX-101.SCH) — 3KB
- ispc-20240911_lab.xml (EX-101.LAB) — 33KB
- ispc-20240911_pre.xml (EX-101.PRE) — 22KB
- tm2423782d1_8k_htm.xml (XML) — 4KB
03
Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.
03
Item 5.03 Amendment to Articles of Incorporation or Bylaws, Change in Fiscal Year. On July 19, 2024, iSpecimen Inc. (the "Company" ) held its annual meeting of stockholders (the "Annual Meeting" ). At the Annual Meeting, the stockholders approved a proposal to amend the Company's Fourth Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation" ) to effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio in the range from 1-for-10 to 1-for-20, to be determined at the discretion of the Board of Directors of the Company (the "Board" ). On August 19, 2024, the Board approved a one-for-twenty (1:20) reverse stock split of the Company's issued and outstanding shares of common stock (the "Reverse Stock Split" ). The Company intends to file with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the "Certificate of Amendment" ) on September 13, 2024 to effect the Reverse Stock Split. The Reverse Stock Split will become effective as of 4:30 p.m., Eastern Time, on September 13, 2024, and the Company's common stock will begin trading on a split-adjusted basis when the market opens on September 16, 2024. When the Reverse Stock Split becomes effective, every twenty (20) shares of the Company's issued and outstanding common stock (and such shares held in treasury) will automatically be converted into one share of common stock, without any change in the par value per share. In addition, (i) a proportionate adjustment will be made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock, (ii) a proportionate adjustment will also be made in the number of shares of common stock issuable upon the vesting of restricted stock units, and (iii) the number
01
Item 7.01. Regulation FD Disclosure. On September 11, 2024, the Company issued a press release announcing the Reverse Stock Split. The press release is furnished as Exhibit 99.1 and incorporated by reference herein. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished, shall not be deemed "filed" for any purpose, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Form of Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation of iSpecimen Inc. 99.1 Press Release dated September 11, 2024 announcing the Reverse Stock Split. 104 Cover Page Interactive Data File (embedded within Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 11, 2024 iSPECIMEN INC. By: /s/ Tracy Curley Name: Tracy Curley Title: Chief Executive Officer